Navigation

Poster

P1

Influence of combined therapy on inflammatory state and pro-inflammatory cytokines in patients with coronary artery disease and metabolic syndrome

J. Uzokov1, A. Alyavi1, S. Azizov1, B. Alyavi1 (1Tashkent UZ)

View abstract


P2

Association of Hyperhomocysteinemia with Acute Myocardial Infarction in Iraqi Patients

S. Othman Amen1, S. Tharwat Baban2 (1Rostock DE; 2Nottingham GB)

View abstract


P3

Association of Vitamin D Deficiency with Acute Myocardial Infarction in Iraqi Patients

S. Othman Amen1, S. Tharwat Baban2 (1Rostock DE; 2Nottingham GB)

View abstract


P4

Adherence to Statin therapy drives survival of patients with symptomatic peripheral artery disease

J. Dopheide1, J. Veit1, H. Ramadani1, L. Adam1, L. Papac1, M. Schindewolf1, A. Vonbank2, I. Baumgartner1, H. Drexel1 (1Bern ; 2Feldkirch AT)

View abstract


P5

Prescription of sacubitril/valsartan in patients with heart failure and reduced ejection fraction attending to an outpatient heart failure clinic

M. Rizzo1, I. Colomer-Asenjo1, M. Sutil-Vega1, G. Cabello-Molina1, S. Marín-López1, F. Taibi-Hajjami1, C. Roca-Guerrero1, D. García-Vega1, M. Panelo-Rubio1, M. Bonastre-Thio1, A. Martínez-Rubio1 (1Sabadell (Barcelona) ES)

View abstract


P6

Tolerability profile and discontinuation causes of sacubitril/valsartan treatment in “real-life” patients with heart failure and reduced ejection fraction

M. Rizzo1, I. Colomer-Asenjo1, M. Sutil-Vega1, G. Cabello-Molina1, S. Marín-López1, F. Taibi-Hajjami1, C. Roca-Guerrero1, D. García-Vega1, M. Panelo-Rubio1, M. Bonastre-Thio1, A. Martínez-Rubio1 (1Sabadell (Barcelona) ES)

View abstract


P7

Mechanisms of cardiotoxicity associated with tyrosine kinase inhibitors in H9c2 cells and mice

J. Bouitbir1, A. Alshaikhali1, M. Panajatovic1, V. Abegg1, F. Paech1, S. Krähenbühl1 (1Basel)

View abstract


P8

Direct oral anticoagulants concentration testing in clinical practice for high-risk patients with atrial fibrillation

K. Pukite1, I. Urtane1, I. Pupkevica1, I. Cernevska1, O. Boicuka1, J. Meisters1, D. Straupmane1, A. Lejnieks1, A. Strelnieks1, O. Kalejs1 (1Riga LV)

View abstract


P9

Role of PGC-1α associated mitochondrial biogenesis in statin-induced myotoxicity

M. Panajatovic1, F. Singh1, U. Duthaler1, S. Krähenbühl1, J. Bouitbir1 (1Basel)

View abstract


P10

Blood Lead Level and Hypertension Risk in the United States National Health Nutrition and Examination Survey (NHANES) 1999-2016

B. M. Y. Cheung1, M. F. Tsoi1, K. K. W. Lui1, T. T. Cheung1 (1Hong Kong HK)

View abstract


P11

Evaluation of the effect of HFRT on the anthropometric obesity parameters in Patients of Chronic Heart Failure – A retrospective analysis

R. Sane (Mumbai IN)

View abstract


P12

The Role of the Central Autonomic Nervous System and Psychosocial Factors in Microvascular Angina and Tako-Tsubo Syndrome

M. Cattaneo1, M. M. Cattaneo2, E. Pravatà3, M. Provenzi4, M. Moccetti3, A. Kaelin3, I. Sudano5, F. Crea6, L. Biasucci6, C. Limoni3, C. Calanchini7, A. Gallino8 (1Bellinzona / Lugano ; 2 Bellinzona ; 3Lugano ; 4Stabio ; 5Zurich ; 6Rome IT; 7Castelrotto ; 8Bellinzona / Zurich)

View abstract


P13

Evaluation of the effect of Heart Failure Reversal Therapy (HFRT) on the Exercise Capacity in patients with Chronic Heart Failure and their association with co-morbidities  

R. Sane (Mumbai IN)

View abstract


P14

Network Meta-analysis to Determine the Optimal Level of Systolic Blood Pressure for Hypertensive Patients

B. M. Y. Cheung1, Y. Fei1, M. F. Tsoi1 (1Hong Kong HK)

View abstract


P15

Cardiovascular benefits of new antidiabetic drug classes: a network meta-analysis

B. M. Y. Cheung1, Y. Fei1, M. F. Tsoi1 (1Hong Kong HK)

View abstract


P16

The perilousness of antidepressant drugs in a real-world cohort of patients with acute coronary syndrome.

A. Denegri1, L. Raeber2, S. Windecker2, B. Gencer3, F. Mach3, N. Rodondi2, D. Heg2, D. Nanchen4, C. Matter5, T. F. Luescher5 (1Mantova IT; 2Bern ; 3Geneva ; 4Lausanne ; 5Zurich)

View abstract


P17

Protocol of A Randomized, Single blind, placebo -controlled RESCAP, intervention study to determine the safety of RESCAP  in Diabetes: RAPID protocol-Rational and design.

V. Popov1, R. Brands2, N. Bulanova1 (1Moscow RU; 2Wageningen NL)

View abstract


P18

Evaluating the potential effect of L-Carnitine on the prevention of atrial fibrillation following coronary artery bypass graft surgery: a Randomized Clinical Trial

F. Dastan (Tehran TR)

View abstract


P19

HYPOTENSIVE ACTION OF MELATONIN IN PATIENTS WITH ARTERIAL HYPERTENSION

N. Bulanova1, E. Ahsanova1, V. Popov1, T. Morozova1 (1Moscow RU)

View abstract


P20

Statins and insulin resistance

G. M. Sanvee1, M. Panajatovic1, D. J. Bouitbir1, D. M. D. P. S. Krähenbühl1 (1Basel)

View abstract


P21

Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target

E. Osto1, A. Jomard1, P. Doytcheva1, O. Chavez-Talavera2, A. Tailleux2, B. Staels2, A. von Eckardstein1, C. Wolfrum3, F. Ruschitzka4, T. Lutz4 (1Schlieren-Zurich ; 2Lille FR; 3Schwerzenbach ; 4Zurich)

View abstract


P22

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy

M. Matsuda (Kure, Hiroshima JP)

View abstract


P23

Comorbidity differentiation and risk stratification in the elderly patient with polypharmacy: a prospective primary care registry on oral anticoagulation therapy

S. van Vugt1, G. Aarts1, E. Lamfers1, L. Bloem - de Vries1, M. J. de Boer1, F. Verheugt1, J. Jaspers Focks1, M. Brouwer1, C. Kramers1 (1Nijmegen NL)

View abstract


P24

A multicenter, open-label, randomized controlled clinical trial to assess the efficacy and safety of appropriate target values for lipid management in patients who have mild to moderate stenotic lesions with high-risk plaques in coronary arteries: Study protocol

M. Matsuda1, K. Hasegawa2 (1Kure, Hiroshima JP; 2Kyoto JP)

View abstract